Antony C. Mattessich Purchases 6,500 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) CEO Antony C. Mattessich bought 6,500 shares of the firm’s stock in a transaction on Wednesday, August 30th. The stock was acquired at an average price of $3.81 per share, for a total transaction of $24,765.00. Following the transaction, the chief executive officer now owns 6,500 shares […]

Related Keywords

United States ,Dekabank Deutsche Girozentrale ,Antonyc Mattessich ,Robertw Baird ,Ahrens Investment Partners ,Sg Americas Securities ,Nasdaq ,Deltec Asset Management ,Aristides Capital ,Ocular Therapeutix Inc ,Ocular Therapeutix ,Get Free Report ,Investment Partners ,Bank Deutsche Girozentrale ,Asset Management ,Resure Sealant ,Ocular Therapeutix Daily ,Nasdaq Ocul ,Hocul ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,